CHARACTERIZATION OF MUTATIONS IN ASXL1, SRSF2, CBL AND JAK2 GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA

被引：0

作者：

Palomo, L. ^{[1
]}

Xicoy, B. ^{[2
]}

Marce, S. ^{[2
]}

Garcia, O. ^{[2
]}

Cabezon, M. ^{[2
]}

Jimenez, M. ^{[2
]}

Arnan, M. ^{[3
]}

Pomares, H. ^{[3
]}

Alonso, E. ^{[3
]}

Granada, I. ^{[2
]}

Ribera, J. ^{[2
]}

Sole, F. ^{[1
]}

Ribera, J. ^{[2
]}

Feliu, E. ^{[2
]}

Milla, F. ^{[2
]}

Zamora, L. ^{[2
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst, Myelodysplast Syndromes Grp, Badalona, Spain

[2] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst ICO, Hematol, Badalona, Spain

[3] Hosp Duran & Reynals, ICO, Hematol, Barcelona, Spain

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P262

引用

页码：112 / 112

页数：1

共 50 条

[21] EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
Mrinal M. Patnaik
Rangit Vallapureddy
Terra L. Lasho
Katherine P. Hoversten
Christy M. Finke
Rhett Ketterling
Curtis Hanson
Naseema Gangat
Ayalew Tefferi
Blood Cancer Journal, 8
[22] EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
Patnaik, Mrinal M.
Vallapureddy, Rangit
Lasho, Terra L.
Hoversten, Katherine P.
Finke, Christy M.
Ketterling, Rhett
Hanson, Curtis
Gangat, Naseema
Tefferi, Ayalew
BLOOD CANCER JOURNAL, 2018, 8
[23] Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis
Jafari, Pourya Arbab
Ayatollahi, Hossein
Sadeghi, Ramin
Sheikhi, Maryam
Asghari, Amir
HEMATOLOGY, 2018, 23 (10) : 778 - 784
[24] Comprehensive Genetic Analyses Of 213 PMF Patients Revealed 13% Of SRSF2 Mutations Being Strongly Correlated To ASXL1 Mutations
Meggendorfer, Mania
Alpermann, Tamara
Eder, Christiane
Haferlach, Claudia
Kern, Wolfgang
Haferlach, Torsten
Schnittger, Susanne
BLOOD, 2013, 122 (21)
[25] Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia
Ouyang, Yuan
Qiao, Chun
Chen, Yu
Zhang, Su-Jiang
ONCOTARGET, 2017, 8 (13) : 20834 - 20841
[26] Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL
Tran, Ann
Wong, Michelle
BLOOD, 2021, 138 (26) : 2890 - 2890
[27] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A Tefferi
Leukemia, 2010, 24 : 1128 - 1138
[28] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
Tefferi, A.
LEUKEMIA, 2010, 24 (06) : 1128 - 1138
[29] Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia
Braun, Theodore
Foley, Amy
Druker, Brian J.
Maxson, Julia E.
BLOOD, 2018, 132
[30] The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia
Federmann, Birgit
Abele, Manuel
Cuesta, David Santiago Rosero
Vogel, Wichard
Boiocchi, Leonardo
Kanz, Lothar
Quintanilla-Martinez, Leticia
Orazi, Attilio
Bonzheim, Irina
Fend, Falko
HUMAN PATHOLOGY, 2014, 45 (12) : 2471 - 2479

← 1 2 3 4 5 →